Mymetics Corp (MYMX)

[bow-tie]

Mr. K can you tell me why this Malaria vaccine is not being used today? Why it has not been FAST TRACK to be used in sub-sahra regions. What are you doing?

EPALINGES, SWITZERLAND–(Marketwired – April 5, 2016) – Mymetics Corporation (OTCQB:MYMX), a pioneer in the research and development of virosome based vaccines to prevent transmission of human infectious diseases, announced today that the preclinical study with Mymetics’ virosome based formulations for a malaria transmission-blocking vaccine candidate has been successful. The study showed that the virosome vaccine candidates, at the highest dose tested, generate high antibody titers against the required antigens and they were able to significantly reduce (97-100%) the transmission of the Plasmodium falciparum parasite.

https://investingnews.com/daily/life-science-investing/biotech-investing/mymetics-announces-successful-preclinical-results-malaria-transmission-blocking-vaccine-candidate/